Prevalence of psychotropic use in a South Australian population

REFERENCES

• Ohayon M M, Caulet M, Priest R G, Guilleminault C. Psychotropic medication consumption patterns in the UK general population. Journal of Clinical Epidemiology 1998; 51: 273–283
   PubMed Web of Science ®Google Scholar
• Paulose-Ram R, Jonas B S, Orwig D, Safran M A. Prescription psychotropic medication use among the U.S. adult population: results from the third National Health and Nutrition Examination Survey, 1988–1994. Journal of Clinical Epidemiology 2004; 57: 309–317
   PubMed Web of Science ®Google Scholar
• Ohayon M M, Lader M H. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. Journal of Clinical Psychiatry 2002; 63: 817–825
   PubMed Web of Science ®Google Scholar
• Beck C A, Williams J V, Wang J L, et al. Psychotropic medication use in Canada. Canadian Journal of Psychiatry 2005; 50: 605–613
   PubMed Web of Science ®Google Scholar
• Jorm A F, Grayson D, Creasey H, et al. Long-term benzodiazepine use by elderly people living in the community. Australian and New Zealand Journal of Public Health 2000; 24: 7–10
   PubMed Web of Science ®Google Scholar
• Mant A, Whicker S D, McManus P, et al. Benzodiazepine utilisation in Australia: report from a new pharmacoepidemiological database. Australian Journal of Public Health 1993; 17: 345–349
   PubMedGoogle Scholar
• Conley R R, Kelly D L, Lambert T J, Love R C. Comparison of clozapine use in Maryland and in Victoria, Australia. Psychiatric Services 2005; 56: 320–323
   PubMed Web of Science ®Google Scholar
• Mond J, Morice R, Owen C, Korten A. Use of antipsychotic medications in Australia between July 1995 and December 2001. Australian and New Zealand Journal of Psychiatry 2003; 37: 55–61
   PubMed Web of Science ®Google Scholar
• McManus P, Mant A, Mitchell P, et al. Use of antidepressants by general practitioners and psychiatrists in Australia. Australian and New Zealand Journal of Psychiatry 2003; 37: 184–189
   PubMed Web of Science ®Google Scholar
• Mant A, Rendle V A, Hall W D, et al. Making new choices about antidepressants in Australia: the long view 1975–2002. Medical Journal of Australia 2004; 181: S21–S24
   PubMed Web of Science ®Google Scholar
• McManus P, Mant A, Mitchell P B, et al. Recent trends in the use of antidepressant drugs in Australia, 1990–1998. Medical Journal of Australia 2000; 173: 458–461
   PubMed Web of Science ®Google Scholar
• Government of South Australia Department of Health. Population Research and Outcome Studies. Health Omnibus. 2004, SA Department of Health: http://www.dh.sa.gov.au/pehs/PROS/HOS.html. Accessed 16 March 2006
   Google Scholar
• Australian Bureau of Statistics. Population by Age and Sex, Australian States and Territories. Australian Bureau of Statistics, Canberra 2001, (Catalogue Number 3201.0)
   Google Scholar
• Australian Government Department of Health and Ageing. Schedule of Pharmaceutical Benefits for Approved Pharmacists and Medical Practitioners. Australian Government Department of Health and Ageing, Canberra 2004
   Google Scholar
• WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical Classification. World Health Organization. 2006, http://www.whocc.no/atcddd/. Accessed 16 March 2006
   Google Scholar
• Lockwood A, Berbatis C G. Psychotropic drugs in Australia: consumption patterns. Medical Journal of Australia 1990; 153: 604–611
   PubMed Web of Science ®Google Scholar
• Isacsson G. Suicide prevention –a medical breakthrough?. Acta Psychiatrica Scandinavica 2000; 102: 113–117
   PubMed Web of Science ®Google Scholar
• Australian Bureau of Statistics. National Health Survey: Summary of Results, 2004–05. Australian Bureau of Statistics, Canberra 2006, (Catalogue Number 4364.0)
   Google Scholar
• Beck C A, Patten S B, Williams J V, et al. Antidepressant utilization in Canada. Social Psychiatry and Psychiatric Epidemiology 2005; 40: 799–807
   PubMed Web of Science ®Google Scholar
• Rossi S. Australian Medicines Handbook 2006. Australian Medicines Handbook, Adelaide 2006
   Google Scholar
• Jablensky A, McGrath J, Herrman H, et al. Psychotic disorders in urban areas: an overview of the Study on Low Prevalence Disorders. Australian and New Zealand Journal of Psychiatry 2000; 34: 221–236
   PubMed Web of Science ®Google Scholar
• Goldney R D, Fisher L J, Grande E D, et al. Bipolar I and II disorders in a random and representative Australian population. Australian and New Zealand Journal of Psychiatry 2005; 39: 726–729
   PubMed Web of Science ®Google Scholar
• Muller-Oerlinghausen B, Berghofer A, Ahrens B. The antisuicidal and mortalityreducing effect of lithium prophylaxis: consequences for guidelines in clinical psychiatry. Canadian Journal of Psychiatry 2003; 48: 433–439
   PubMed Web of Science ®Google Scholar
• Cumming R G, Klineberg R J. Psychotropics, thiazide diuretics and hip fractures in the elderly. Medical Journal of Australia 1993; 158: 414–417
   PubMed Web of Science ®Google Scholar
• Shorr R I, Robin D W. Rational use of benzodiazepines in the elderly. Drugs and Aging 1994; 4: 9–20
   PubMed Web of Science ®Google Scholar
• Goldney R D, Fisher L J, Dal Grande E, Taylor A W. Changes in mental health literacy about depression: South Australia, 1998–2004. Medical Journal of Australia 2005; 183: 134–137
   PubMed Web of Science ®Google Scholar
• Jorm A F, Christensen H, Griffiths KM. Changes in depression awareness and attitudes in Australia: the impact of beyondblue: the national depression initiative. Australian and New Zealand Journal of Psychiatry 2006; 40: 42–46
   PubMed Web of Science ®Google Scholar
• Jorm A F, Christensen H, Griffiths KM. The impact of beyondblue: the national depression initiative on the Australian public’s recognition of depression and beliefs about treatments. Australian and New Zealand Journal of Psychiatry 2005; 39: 248–254
   PubMed Web of Science ®Google Scholar